🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
150,33 USD
Máx. histórico
156,92
10 días
Caída desde máximo
-4,20%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,32%
Cierre anterior
152,34
Rango de hoy
150,09 – 152,22
Volumen hoy
4.298.143
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 122,22 (puede no estar actualizado)
- Dividend yield
- 2,23% (puede no estar actualizado)
- Precio objetivo analistas
- 148,73 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 2 días
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 02/12/1992 | 0,1193 USD |
| 31/08/1992 | 0,1193 USD |
| 02/06/1992 | 0,1097 USD |
| 02/03/1992 | 0,1097 USD |
| 02/12/1991 | 0,1002 USD |
| 30/08/1991 | 0,1002 USD |
| 03/06/1991 | 0,0891 USD |
| 04/03/1991 | 0,0891 USD |
| 03/12/1990 | 0,0891 USD |
| 28/08/1990 | 0,0891 USD |
| 29/05/1990 | 0,0716 USD |
| 05/03/1990 | 0,0716 USD |
| 04/12/1989 | 0,0716 USD |
| 29/08/1989 | 0,0716 USD |
| 30/05/1989 | 0,0652 USD |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 08/12/2015 | 51,12 | 51,91 | 50,78 | 51,02 | -0,39% | 2,20% | 7.936.714 |
| 07/12/2015 | 51,55 | 51,75 | 50,74 | 51,22 | +0,07% | 1,94% | 9.113.408 |
| 04/12/2015 | 50,45 | 51,22 | 50,41 | 51,18 | +2,00% | 1,61% | 14.343.976 |
| 03/12/2015 | 51,59 | 51,61 | 49,85 | 50,18 | -2,29% | 3,42% | 14.247.665 |
| 02/12/2015 | 52,16 | 52,47 | 51,29 | 51,36 | -1,37% | 2,27% | 10.584.066 |
| 01/12/2015 | 51,31 | 52,14 | 50,99 | 52,07 | +2,94% | 2,23% | 13.620.646 |
| 30/11/2015 | 51,56 | 51,63 | 50,57 | 50,58 | -1,76% | 2,05% | 14.004.634 |
| 27/11/2015 | 50,92 | 51,72 | 50,92 | 51,49 | +0,45% | 1,57% | 3.124.717 |
| 25/11/2015 | 51,16 | 51,45 | 51,01 | 51,26 | +0,45% | 0,86% | 6.370.687 |
| 24/11/2015 | 51,11 | 51,22 | 50,67 | 51,03 | -0,98% | 1,08% | 11.011.546 |
| 23/11/2015 | 51,60 | 51,72 | 51,32 | 51,54 | -0,17% | 0,78% | 9.105.129 |
| 20/11/2015 | 52,11 | 52,35 | 51,53 | 51,62 | -0,33% | 1,57% | 9.362.098 |
| 19/11/2015 | 51,95 | 52,03 | 51,45 | 51,79 | +0,09% | 1,12% | 7.167.482 |
| 18/11/2015 | 51,39 | 51,83 | 51,24 | 51,75 | +0,97% | 1,15% | 11.330.347 |
| 17/11/2015 | 51,25 | 51,81 | 50,85 | 51,25 | +0,02% | 1,88% | 7.468.677 |
| 16/11/2015 | 49,80 | 51,35 | 49,74 | 51,24 | +1,26% | 3,22% | 7.239.374 |
| 13/11/2015 | 51,01 | 51,26 | 50,48 | 50,60 | +0,00% | 1,53% | 11.941.436 |
| 12/11/2015 | 51,14 | 51,50 | 50,60 | 50,60 | -1,28% | 1,75% | 8.989.220 |
| 11/11/2015 | 52,30 | 52,48 | 51,22 | 51,26 | -1,30% | 2,41% | 8.954.741 |
| 10/11/2015 | 51,89 | 52,10 | 51,55 | 51,94 | +0,35% | 1,07% | 7.820.490 |
| 09/11/2015 | 51,56 | 51,92 | 51,28 | 51,76 | -0,68% | 1,24% | 9.578.930 |
| 06/11/2015 | 52,28 | 52,37 | 51,54 | 52,11 | -0,80% | 1,59% | 11.237.704 |
| 05/11/2015 | 52,92 | 53,13 | 52,18 | 52,53 | -0,86% | 1,80% | 9.481.046 |
| 04/11/2015 | 52,93 | 53,22 | 52,65 | 52,99 | +0,76% | 1,06% | 8.121.162 |
| 03/11/2015 | 52,56 | 52,84 | 51,98 | 52,59 | +0,00% | 1,63% | 9.658.578 |
| 02/11/2015 | 52,19 | 52,80 | 51,92 | 52,59 | +0,82% | 1,68% | 11.065.937 |
| 30/10/2015 | 52,28 | 52,74 | 52,16 | 52,16 | -0,38% | 1,11% | 11.546.235 |
| 29/10/2015 | 52,44 | 53,09 | 51,98 | 52,36 | -0,42% | 2,13% | 9.334.850 |
| 28/10/2015 | 51,52 | 52,61 | 51,10 | 52,58 | +3,05% | 2,95% | 15.416.080 |
| 27/10/2015 | 51,30 | 51,62 | 50,36 | 51,02 | +1,06% | 2,46% | 14.626.831 |